Comoglio PM - Search Results

1

Drug development of MET inhibitors: targeting oncogene addiction and expedience.

Comoglio PM, Giordano S, Trusolino L. Comoglio PM, et al. Nat Rev Drug Discov. 2008 Jun;7(6):504-16. doi: 10.1038/nrd2530. Nat Rev Drug Discov. 2008. PMID: 18511928 Review.

2

The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.

Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S. Petrelli A, et al. Among authors: comoglio pm. Nature. 2002 Mar 14;416(6877):187-90. doi: 10.1038/416187a. Nature. 2002. PMID: 11894096

3

Invasive growth: from development to metastasis.

Comoglio PM, Trusolino L. Comoglio PM, et al. J Clin Invest. 2002 Apr;109(7):857-62. doi: 10.1172/JCI15392. J Clin Invest. 2002. PMID: 11927611 Free PMC article. Review. No abstract available.

4

An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity.

Michieli P, Cavassa S, Basilico C, De Luca A, Mazzone M, Asti C, Chiusaroli R, Guglielmi M, Bossù P, Colotta F, Caselli G, Comoglio PM. Michieli P, et al. Among authors: comoglio pm. Nat Biotechnol. 2002 May;20(5):488-95. doi: 10.1038/nbt0502-488. Nat Biotechnol. 2002. PMID: 11981563

5

Scatter-factor and semaphorin receptors: cell signalling for invasive growth.

Trusolino L, Comoglio PM. Trusolino L, et al. Among authors: comoglio pm. Nat Rev Cancer. 2002 Apr;2(4):289-300. doi: 10.1038/nrc779. Nat Rev Cancer. 2002. PMID: 12001990 Review.

6

The semaphorin 4D receptor controls invasive growth by coupling with Met.

Giordano S, Corso S, Conrotto P, Artigiani S, Gilestro G, Barberis D, Tamagnone L, Comoglio PM. Giordano S, et al. Among authors: comoglio pm. Nat Cell Biol. 2002 Sep;4(9):720-4. doi: 10.1038/ncb843. Nat Cell Biol. 2002. PMID: 12198496

7

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.

Lorenzato A, Olivero M, Patanè S, Rosso E, Oliaro A, Comoglio PM, Di Renzo MF. Lorenzato A, et al. Among authors: comoglio pm. Cancer Res. 2002 Dec 1;62(23):7025-30. Cancer Res. 2002. PMID: 12460923

8

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Pennacchietti S, et al. Among authors: comoglio pm. Cancer Cell. 2003 Apr;3(4):347-61. doi: 10.1016/s1535-6108(03)00085-0. Cancer Cell. 2003. PMID: 12726861 Free article.

9

Mutations in the met oncogene unveil a "dual switch" mechanism controlling tyrosine kinase activity.

Chiara F, Michieli P, Pugliese L, Comoglio PM. Chiara F, et al. Among authors: comoglio pm. J Biol Chem. 2003 Aug 1;278(31):29352-8. doi: 10.1074/jbc.M302404200. Epub 2003 May 12. J Biol Chem. 2003. PMID: 12746450 Free article.

10

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness.

Maggiora P, Lorenzato A, Fracchioli S, Costa B, Castagnaro M, Arisio R, Katsaros D, Massobrio M, Comoglio PM, Flavia Di Renzo M. Maggiora P, et al. Among authors: comoglio pm. Exp Cell Res. 2003 Aug 15;288(2):382-9. doi: 10.1016/s0014-4827(03)00250-7. Exp Cell Res. 2003. PMID: 12915129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page